Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program
5/23/2013
More...
|
Novartis AG (NVS) Ramps Up Alzheimer's Drug Pursuit as Rivals Fail
5/23/2013
More...
|
Pfizer Inc. (PFE) Takes Its Shot at a Vaccine for Evasive MRSA Superbug
5/23/2013
More...
|
H. Lundbeck A/S (LUN.CO) Release: Vortioxetine, a New Multimodal Agent in Development for the Treatment of Major Depression, Shows Effects on Cognitive Function in Several Preclinical Animal Models
5/22/2013
More...
|
Alnylam Pharmaceuticals (ALNY) Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
5/17/2013
More...
|
Mesoblast Limited's Preclinical Trial Results of Intracoronary Cell Therapy Published in Circulation Research
5/15/2013
More...
|
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives
5/15/2013
More...
|
Senesco Technologies, Inc. (SNT) Announces Presentation on Combination Therapy With Novel Nanoparticle, SNS01-T, and Bortezomib Results in Synergistic Cytotoxicity In Vitro and In Vivo in Multiple Myeloma
5/14/2013
More...
|
Pluristem Therapeutics (PSTI) Release: Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia
5/13/2013
More...
|
SANUWAVE, Inc. Completes Investigator Meeting
5/13/2013
More...
|
Starpharma Holdings Ltd's Dendrimer a Potential Viral Conjunctivitis Treatment
5/13/2013
More...
|
Novavax, Inc. (NVAX) H7N9 VLP Influenza Vaccine Enters Animal Testing
5/10/2013
More...
|
Acceleron Pharma’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes
5/10/2013
More...
|
Acorda Therapeutics (ACOR) Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in Stroke
5/9/2013
More...
|
Precision Therapeutics, Inc. Presents Clinical Data Demonstrating Prediction for Platinum Resistance to First-Line Chemotherapy in Primary Ovarian Cancer at WAGO
5/9/2013
More...
|
Differences Between "Marathon Mice" and "Couch Potato Mice" Reveal Key to Muscle Fitness, Sanford-Burnham Medical Research Institute Study
5/8/2013
More...
|
Ablynx Starts Pre-Clinical Development of ALX-0962, an Anti-IgE Nanobody, to Treat Severe Allergic Asthma
5/7/2013
More...
|
Nuvilex Shows Success Treating Mammary Tumors Using Cell Encapsulation Technology
5/7/2013
More...
|
Vical Incorporated (VICL) Release: Vaxfectin® Enhances Preclinical Immune Responses to Baxter's Cell Culture-Derived Influenza Vaccines
5/6/2013
More...
|
Kala Pharmaceuticals Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor
5/6/2013
More...
|
CEL-SCI (CVM) Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model
5/6/2013
More...
|
Emergent BioSolutions (EBS) Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer
5/3/2013
More...
|
Amgen (AMGN) Drugs May Boost Survival During a Nuclear Attack
5/3/2013
More...
|
Addex Therapeutics (ADXN.SW) Reports that Dipragluant Demonstrated Dose-Dependent mGlu5 Receptor Occupancy in a Non-Human Primate PET Study
5/1/2013
More...
|
Addex Therapeutics (ADXN.SW) Reports ADX71441 Reduces Alcohol Intake in a Preclinical Model of Chronic Alcohol Dependence
4/30/2013
More...
|
Cannabis Science Inc. Announces Preclinical Development Program for CS-TATI-I, Commencing EU Operations in the Netherlands and Sourcing Proprietary Material for Pharmacokinetic Characterization
4/29/2013
More...
|
Galectin Therapeutics Inhibitors Reverse Liver Cirrhosis in Preclinical Studies
4/29/2013
More...
|
Evotec AG (EVTG.F): New Hormone to Treat Diabetes Published in "Cell"
4/26/2013
More...
|
Wyatt Technology Corporation Calypso Succeeds in ABRF-MIRG Study
4/25/2013
More...
|
arGEN-X Advances ARGX-113 Into Preclinical Development for Autoimmune Disorders
4/24/2013
More...
|
NicOx SA (COX.PA) Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference
4/24/2013
More...
|
Bionomics Limited (BMICY.PK) Release: Manufacture of BNC101 Commences at Lonza
4/23/2013
More...
|
Addex Therapeutics (ADXN.SW) Dipraglurant Normalizes Striatal Cholinergic Dysfunction in a Validated Preclinical Model of Primary Generalized Torsion Dystonia 1 (DYT1)
4/18/2013
More...
|
Galectin Therapeutics to Present New Data on the Treatment of Liver Fibrosis and Cirrhosis
4/17/2013
More...
|
Data on SEEK's Novel Immunotherapy for HIV Published in Virology Journal Antibody Treatment for HIV
4/16/2013
More...
|
Innate Pharma (IPH.PA ) Presents New Data for Proprietary Programs Targeting TLR3 and KIR3DL2
4/12/2013
More...
|
Amarantus BioSciences, Inc. Announces Preclinical Development Timeline for MANF Therapeutic
4/11/2013
More...
|
Emergent BioSolutions (EBS) Presents Efficacy Data on ES210; a Bispecific ADAPTIR Molecule for Treating Autoimmune Diseases
4/11/2013
More...
|
Merrimack Pharmaceuticals Inc.' Preclinical Research Shows MM-111 Restores Sensitivity to Chemotherapy and HER2-targeted Treatment in Gastric Cancer Model
4/10/2013
More...
|
ImmunoGen, Inc. (IMGN) Announces Preclinical Findings With Its IMGN289 Product Candidate for the Treatment of EGFR-Overexpressing Cancers
4/10/2013
More...
|
Data Presented at American Association for Cancer Research Annual Meeting Support Targeted Immune Reactivation Mechanism and Potential of Peregrine Pharmaceuticals, Inc. (PPHM)'s Bavituximab in Solid Tumor Therapy
4/10/2013
More...
|
Preclinical Data Presented at American Association for Cancer Research Describe a Mechanism of Action of Exelixis, Inc. (EXEL)'s Cabozantinib in a Prostate Cancer Bone Metastasis Model
4/10/2013
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Presents Preclinical Data Supporting DNA-Based IL-12 Therapy for Breast Cancer
4/9/2013
More...
|
Sunshine Biopharma, Inc. HMEC Study Indicates Novel Anticancer Compound Adva-27a Non-Toxic at High Concentrations
4/9/2013
More...
|
Mersana Therapeutics, Inc. Presents Positive Preclinical Data on Next-Generation Antibody-Drug Conjugate Technology at American Association for Cancer Research Annual Meeting
4/9/2013
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) Presents New Preclinical Data Showing Ponatinib is a Potent Inhibitor of RET and FGFR, Two Oncogenic Drivers of Non-Small Cell Lung Cancer
4/8/2013
More...
|
Merrimack Pharmaceuticals Inc.' Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
4/8/2013
More...
|
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100
4/8/2013
More...
|
Spirogen Ltd. and Bioatla Present Positive Data on Next-Generation Warheads in ADCS Against Cancer
4/8/2013
More...
|
Arno Therapeutics Reports Activated Progesterone Receptors Predictive of Response to Onapristone
4/8/2013
More...
|
Agios Pharmaceuticals Publishes Two Articles in Science Demonstrating the Effects of Mutant IDH1 and IDH2 Inhibitors in Primary Tumor Models
4/5/2013
More...
|
Pozen, Inc. (POZN) Announces Results From a Burden of Cardiovascular Disease Study: a Managed Care Perspective
4/5/2013
More...
|
Chikujee Therapeutics Presents Updates on Development Program for Lead Therapeutic Candidate
4/3/2013
More...
|
Scimera BioScience Release: New Product Created in South Florida May Help Millions Who Suffer From G.I. Side Effects of Antibiotics
4/3/2013
More...
|
Ensemble Therapeutics Corporation to Present Data on IL-17A Inhibitors that are Novel, Oral Macrocycles Against Previously Undruggable Target
4/1/2013
More...
|
Premier Biomedical Announces Next Phase of Laboratory Testing of Its Anti-Cancer Therapy
3/28/2013
More...
|
Successful Vaccine Developments at Themis Bioscience, Pasteur Institute Technology Proves Its Effective Potential
3/27/2013
More...
|
Amarantus BioSciences, Inc. Reports Positive MANF Data in Neuroprotection Animal Models of Parkinson's Disease
3/27/2013
More...
|
Arrowhead Research Corporation (ARWR) Induces 90% Reduction in Hepatitis B Antigens in Chimpanzee With Chronic Infection: Data Follow Previous Report of Reduction in Viral DNA
3/25/2013
More...
|
arGEN-X Announces Preclinical Development of ARGX-112 for Dermatology
3/25/2013
More...
|
International Stem Cell Corporation Announces Positive Stem Cell Data in Parkinson's Disease
3/20/2013
More...
|
International Stem Cell Corporation Announces Positive Results of Primate Parkinson's Study
3/19/2013
More...
|
Zalicus Inc. (ZLCS) Presents Data Demonstrating Advantages of State-Dependent Ion Channel Screening
3/19/2013
More...
|
FDA Grants TransTech Pharma, Inc. Fast Track Designation for TTP488 for the Treatment of Alzheimer's Disease
3/19/2013
More...
|
Genocea Biosciences Publishes Preclinical Data for Investigational Vaccine Candidate for HSV-2
3/18/2013
More...
|
Proteome Sciences PLC (PRM.L): Developments in Alzheimer's Disease
3/18/2013
More...
|
Novavax, Inc. (NVAX) Reports Progress on RSV Vaccine at the XV International Symposium on Respiratory Viral Infections
3/18/2013
More...
|
Astrocyte Signaling Sheds Light on Stroke Research, Tulane University School of Medicine Study
3/18/2013
More...
|
Omni Bio Pharmaceutical Announces First Results for Its Lead Recombinant Molecule
3/15/2013
More...
|
Stellar Biotechnologies, Inc. Announces Preclinical Poster at Society of Toxicology (SOT) Showing That Forms and Sources of KLH Matter
3/13/2013
More...
|
GENFIT Corp. (ALGFT) Release: TGFTX1 Program: Successful Identification of Proprietary ROR?t Ligands for the Treatment of Auto-Immune Diseases
3/13/2013
More...
|
RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time of Severe Bone Fractures in Pet Clinical Study
3/12/2013
More...
|
Retrophin, LLC Announces Positive Results From Preclinical Studies of RE-024 for PKAN
3/11/2013
More...
|
Minerva Biotechnologies Corporation Announces Major Breakthrough in Human Stem Cell Research
3/8/2013
More...
|
PRANA Biotechnology (PRAN)'s PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells
3/6/2013
More...
|
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) (SRPT)'s Marburg Drug Shows High Survival Rates After Intramuscular Delivery in Non-Human Primates
3/4/2013
More...
|
Starpharma Holdings Ltd Release: Dendrimers Improve Anticancer Efficacy in Lung Metastasis Model
3/4/2013
More...
|
BioLineRx Ltd.'s EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Therapeutic Pipeline as BL-9010
2/28/2013
More...
|
VIB: New Angle to Combat Malignant Brain Tumors in Children
2/28/2013
More...
|
Roche (RHHBY) Research Sheds Light on Improving Neurological Deficits in Mouse Model of Down Syndrome
2/27/2013
More...
|
Actium BioSystems Demonstrates in Vivo Feasibility of Its Thermal Nanomedicine Cancer Treatment
2/26/2013
More...
|
The Veterinary Bioscience Institute Announces Its Roux-en-Y Gastric Bypass Surgery Model in Rodents
2/26/2013
More...
|
Circassia Limited's Cat Allergy Treatment Shows Sustained Symptom Improvement
2/25/2013
More...
|
Anergis Presents Preclinical Data of its Ragweed Allergy Vaccine Candidate AllerR
2/21/2013
More...
|
Eleven Biotherapeutics Publishes Data on EBI-005, a Novel IL-1 Inhibitor Protein for Topical Treatment of Dry Eye Disease
2/19/2013
More...
|
Orion Corporation Release: Promising Preclinical and Phase I Data of a New Generation Androgen Receptor (AR) Inhibitor, ODM- 201, Presented at American Society of Clinical Oncology GU 2013 Symposium
2/15/2013
More...
|
GTx, Inc. (GTXI) to Present Preclinical Data on a New Therapeutic Target in Prostate Cancer
2/14/2013
More...
|
Genelux Corporation Release: Virus Engineered to Express Melanin Offers New Possibilities to Diagnose and Treat Solid Tumor Cancers
2/13/2013
More...
|
New Publication in Science Shows That Agios Pharmaceuticals' IDH1 Inhibitor Can Reverse Cancer-Causing Effects of Oncometabolite 2-HG in Leukemia Model
2/13/2013
More...
|
International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results in Metabolic Liver Disease Program
2/12/2013
More...
|
Mireven Announces Positive In-Vitro Results for miRNA-7-5p in Melanoma
2/12/2013
More...
|
BioDiem Ltd. (BDM.AX) Progresses to Proof-of-Concept Testing of BDM-I Antimicrobial Effect Against Parasites
2/8/2013
More...
|
Vical Incorporated (VICL) Announces Publication of Herpes Simplex Vaccine Guinea Pig Study Data
2/4/2013
More...
|
International Stem Cell Corporation Announces Positive Results From in Vivo Animal Study of Parkinson's Disease
2/4/2013
More...
|
BioDiem Ltd. (BDM.AX)'s Antimicrobial Tested as Treatment for TB, Fungal Infections, in National Institutes of Health (NIH) Research Program
2/1/2013
More...
|
New Pre-Clinical and Clinical Data on GeNO LLC's Nitric Oxide Delivery Systems to be Presented at 2013 American College of Cardiology and American Thoracic Society Medical Meetings
1/29/2013
More...
|
Addex Therapeutics (ADXN.SW) Dipraglurant Reduces Motor Abnormalities in a Preclinical Model Relevant for Several Rare Types of Dystonia
1/29/2013
More...
|
Cellceutix (CTIX) Reports in Vivo Tumor Shrinkage in Renal Cancer
1/24/2013
More...
|
Auxogyn, Inc. Announces European Expansion of New Non-Invasive Early Embryo Viability Assessment (Eeva(™)) Test With Availability at First Clinic in Ireland
1/24/2013
More...
|
Cellmid Records Positive Data in Midkine Antibody Study in Kidney Disease
1/24/2013
More...
|
Merrimack Pharmaceuticals Inc. to Present Preclinical Data on Bispecific Antibody MM-111 in ErbB2-Positive Gastric Cancers
1/23/2013
More...
|
Mirna Therapeutics, Inc. Presents Preclinical Data on Lead Product Candidate MRX34 at Keystone Conference
1/23/2013
More...
|
New Potential Therapy for Diabetic Kidney Disease: Galectin Therapeutics Announces Anti-Galectin Drug is Effective in Preclinical Studies
1/22/2013
More...
|
Open Monoclonal Technology and Recombinant Antibody Technology Announce OmniRa™ Scientific Publication
1/22/2013
More...
|
IMUGEN Release: First Case Report of New Human Tick-Borne Infection in North America
1/17/2013
More...
|
NanoViricides, Inc. (NNVC.PK) Update: FluCide Drug Candidates Significantly Superior to Tamiflu in Animal Studies Against H3N2 and H1N1 Viruses - Company Announces That cGMP Facility Project has Entered Detailed Design Phase
1/15/2013
More...
|
PolyMedix Inc. (PYMX.OB) Defensin-Mimetic Anti-Malaria Data Published in Cell Host and Microbe
1/14/2013
More...
|
BrainStorm Cell Therapeutics Inc. Establishes Safety of Repeat Doses of NurOwn in Mice; Pre-clinical Study Conducted at GLP-Compliant Harlan Laboratories, Inc.
1/10/2013
More...
|
Addex Therapeutics (ADXN.SW) Announces Positive Data With ADX71441 in a Pre-Clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease
1/7/2013
More...
|
International Stem Cell Corporation Announces Positive Animal Efficacy Results in Liver Disease Program
1/7/2013
More...
|
Revalesio's RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice
1/3/2013
More...
|
Mesenchymal Stem Cells Mobilize Body's Own Healing Cells: STEM CELLS Translational Medicine
12/21/2012
More...
|
AMS Biotechnology (AMSBIO) Release: Integrating Extracellular Matrix Into 3D Spheroid Culture for a High Throughput Cell Invasion Assay
12/21/2012
More...
|
Anima Cell Metrology Scientists Demonstrate Monitoring the Process of Protein Production From Within Living Cells
12/19/2012
More...
|
Transplanted Neural Stem Cells Treat ALS in Mouse Model, Sanford-Burnham Medical Research Institute Study
12/19/2012
More...
|
Etubics Platform Controls HIV and H1N1 Infection in Animal Model
12/18/2012
More...
|
Pfizer Inc. (PFE) Retracts Another Paper Over Failed Drug
12/17/2012
More...
|
Cell Therapeutics, Inc. (CTIC) Release: Preclinical Study Provides Potential Mechanisms for Lower Cardiotoxicity in Patients with Multiply Relapsed or Refractory Aggressive B-cell NHL Treated with PixuvriTM Who Received Prior Doxorubicin Therapy
12/17/2012
More...
|
Single Administration of GenVec Inc. (GNVC)'s Vaccine Provides Protective Immunity Against HSV in Pre-clinical Animal Models
12/17/2012
More...
|
La Jolla Pharmaceutical Company (LJPC) Release: GCS-100 Demonstrates Statistically Significant Reduction in Liver Fibrosis
12/17/2012
More...
|
AMS Biotechnology (AMSBIO) Researchers Respond Enthusiastically to Alvetex 3D Cell Culture
12/14/2012
More...
|
Journal of Huntington's Disease Publishes Benefits of PRANA Biotechnology (PRAN)'s PBT2
12/13/2012
More...
|
Ventria Bioscience Release: In Vivo Characterization of Optiferrin™ Recombinant Human Transferrin Demonstrates Functional Similarity to Serum-Derived Human Transferrin
12/13/2012
More...
|
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
12/13/2012
More...
|
BiondVax Pharmaceuticals' Universal Influenza Vaccine M-001 Significantly Enhances the Efficacy of the Human Pandemic H5N1 Bird Flu Vaccine
12/13/2012
More...
|
Genervon Established That Its Targeted Drug Benefits ALS Disorder Through 8 Pathways and Modulates Over 30 Specific ALS Genes Dynamically
12/13/2012
More...
|
Immunomedics, Inc. (IMMU) Develops New Bispecific Antibodies That Exhibit Potent Anti-Lymphoma Activity
12/12/2012
More...
|
Sangamo BioSciences, Inc. (SGMO) Announces Presentation of Data Demonstrating a Disruptive and Broadly Leverageable Platform for Protein Replacement Therapies at American Society of Hematology Meeting
12/11/2012
More...
|
Precision BioSciences Announces First Publication of Targeted Knockout Rats Using Engineered Meganuclease Technology
12/11/2012
More...
|
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
12/11/2012
More...
|
Immunomedics, Inc. (IMMU) Release: Epratuzumab's B-Cell Modulation Effect Elucidated in Preclinical Study
12/10/2012
More...
|
TG Therapeutics, Inc. (MHA) Announces Poster Presentation Highlights for Ublituximab (TG-1101) and TGR-1202 From the 54th American Society of Hematology Meeting
12/10/2012
More...
|
TetraLogic Pharmaceuticals Announces Presentation on Smac Mimetic Birinapant at American Society of Hematology Annual Meeting
12/10/2012
More...
|
Seattle Genetics, Inc. (SGEN) Highlights Next Generation Antibody-Drug Conjugate SGN-CD33A at American Society of Hematology Annual Meeting
12/10/2012
More...
|
Alnylam Pharmaceuticals (ALNY) Presents New Pre-clinical Data on RNAi Therapeutics for the Treatment of Hemophilia and Other Bleeding Disorders at 54th American Society of Hematology Annual Meeting
12/10/2012
More...
|
Nimbus Discovery IRAK4 Inhibitors Demonstrate Synergistic Effects With BTK Inhibitor Ibrutinib
12/10/2012
More...
|
Concert Pharmaceuticals, Inc. Presents Findings Demonstrating Enhanced Potency of CTP-221, a Deuterated S-Enantiomer of Lenalidomide
12/10/2012
More...
|
Biotech Support Group Release: Cyclic Nucleotide Phosphodiesterases Enrichment Product Cited in Research on Alzheimer's Disease
12/10/2012
More...
|
PROLOR Biotech (PBTH) to Present Preclinical Data on Its Long-Acting Clotting Factor Vlla at 2012 American Society of Hematology Annual Meeting
12/7/2012
More...
|
Isotechnika Pharma Inc. (ISA.TO)'s NICAM Compounds Demonstrate Positive Anti-Hepatitis C Virus Activity in Secondary Level Testing at National Institutes of Health (NIH)-Funded Labs
12/7/2012
More...
|
Cytomedix Inc. (CMXI) Announces Positive Results With Angel® cPRP in Veterinary Application
12/7/2012
More...
|
Eli Lilly and Company (LLY) Tests Med to Rid Brain Plaques In Mice With Alzheimer's
12/6/2012
More...
|
NKT Therapeutics Inc. Presents Data on Potential Antibody Treatment for Sickle Cell Disease
12/6/2012
More...
|
PNAS Publishes Preclinical Results of EntreMed, Inc. (ENMD)'s 2ME2 for Multiple Sclerosis
12/5/2012
More...
|
PRANA Biotechnology (PRAN) Release: Metal Hypothesis for Alzheimer's, Huntington and Other Neurodegenerative Diseases Declared Promising Therapeutic Strategy by Scientists at New York Academy of Sciences Symposium
12/5/2012
More...
|
The Staby® Technology From Delphi Genetics Efficiently Applied to DNA-Vaccine
12/3/2012
More...
|
Stemlogix Reports Idaho Veterinarians Perform First in U.S. Combination Regenerative Medicine Treatment on Injured Horse
12/3/2012
More...
|
Biotech Support Group Release: SeraFILE™ Separations Platform for Functional Proteomic Profiling of Phosphodiesterases
12/3/2012
More...
|
Biotech Support Group Release: Cholesterol Removal From Serum Samples Using Cleanascite™ for Vaccine Research
12/3/2012
More...
|
Biotech Support Group Release: BindPro™ Cited in U.S. Patent 20120296189 Titled Methods of Collecting and Analyzing Samples
12/3/2012
More...
|
Biotech Support Group Release: Albumin Depletion Using Albusorb™ for Proteomic Profiling of Cerebrospinal Fluid
12/3/2012
More...
|
AMSilk Release: Silicone Breast Implants With Spider Silk-Based Coating Show Reduced Side-Effects in Preclinical Studies
11/30/2012
More...
|
Actinium Pharmaceuticals, Inc. and Philogen S.p.A. Announce Start of Pre-Clinical Development of an Alpha Therapy Based Antiangiogenesis Program
11/29/2012
More...
|
Amgen (AMGN) Therapy Slims Monkeys as Study Seeks Obesity Drug
11/29/2012
More...
|
Research Published in European Journal of Pharmacology Shows that Star Scientific , Inc.'s Anatabine Suppresses Brain Inflammation in Animal Model of Alzheimer's Disease and in Blood
11/27/2012
More...
|
Compound Found in Rosemary Pprotects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study
11/27/2012
More...
|
Inovio Pharmaceuticals (INO) Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
11/26/2012
More...
|
Galapagos NV (GLPG.BR) Discovers Novel Class of Antibiotics
11/26/2012
More...
|
A Single Dose of Medicago, Inc.'s H5N1 VLP Vaccine Protects Against Additional Pandemic Flu Strains in a Preclinical Study
11/20/2012
More...
|
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate™ Cell Therapy
11/19/2012
More...
|
Using iPad at Night Could Trigger Depression, Johns Hopkins University Study
11/19/2012
More...
|
Damaged Protein Reveals Parkinson’s Destructive Course, University of Pennsylvania Study
11/16/2012
More...
|
Poor Sleep Can Lead to Schizophrenia Symptoms, University of Bristol Study
11/15/2012
More...
|
How Chronic Inflammation Can Cause Cancer, Ohio State University Study
11/14/2012
More...
|
Promising Data Presented on GenVec Inc. (GNVC) Malaria Program
11/14/2012
More...
|
"Calm Down" Genes Treat Epilepsy in Rats, University College London Study
11/13/2012
More...
|
Ligand Pharmaceuticals Inc. (LGND) Announces Positive Preclinical Data on HepDirect™ Liver-Targeted Antiviral for the Treatment of Hepatitis C
11/13/2012
More...
|
It's Not Just What You Eat, But When You Eat It, University of Pennsylvania Study
11/13/2012
More...
|
Social Isolation Disrupts Brain's "White Matter" Formation, University at Buffalo and Mount Sinai School of Medicine Study
11/12/2012
More...
|
New Precision Therapeutics, Inc. Study Supports Potential Utility of ChemoFx in Primary Ovarian Cancer
11/12/2012
More...
|
Biocryst Pharmaceuticals (BCRX) Broad-Spectrum Antiviral BCX4430 Highly Effective Against Yellow Fever in a Preclinical Disease Model
11/12/2012
More...
|
Ensemble Therapeutics Corporation Presents Oral Efficacy of First-in-Class Small Molecule Targeting IL-17 for Inflammation in Preclinical Studies
11/12/2012
More...
|
Nimbus Discovery Presents Preclinical Data on Highly Selective IRAK4 Inhibitors for the Treatment of Rheumatic Diseases
11/12/2012
More...
|
3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for Study of Liver Diseases Annual Meeting 2012
11/12/2012
More...
|
Inovio Pharmaceuticals (INO) Therapeutic Hepatitis B Vaccine Killer T Cells Demonstrate Potential to Clear HBV in Liver
11/12/2012
More...
|
Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology on the Use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in Preclinical Models of Systemic Lupus Erythematosus (SLE)
11/12/2012
More...
|
Biotech Support Group Release: Albumin Depletion for Secretome Sample Preparation Via AlbuVoid™ for Cellular Modeling Systems
11/12/2012
More...
|
Verastem, Inc. (VSTM) Reports Data on Focal Adhesion Kinase Program at the 2012 European Organization for Research and Treatment of Cancer Symposium on Molecular Targets and Cancer Therapeutics
11/9/2012
More...
|
Arno Therapeutics Reports Progress in Development of Clinical Biomarkers to Support Treatment of Breast Cancer With Onapristone
11/9/2012
More...
|
Vical Incorporated (VICL) Release: Preclinical Data Support Potential Combinations for Allovectin® With Emerging Immunotherapies
11/8/2012
More...
|
AEterna Zentaris (AEZS) Presents Proof-of-Concept for Disorazol Z Cytotoxic Conjugates, Such as AEZS-125, in Ovarian Cancer Mouse Model at ENA Symposium
11/8/2012
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) Presents Systemic, DNA/Cell Plasmid Therapy Showing Long-Term Persistence and Anti-Tumor Effects at EORTC-National Cancer Institute-American Association for Cancer Research Meeting
11/7/2012
More...
|
BioLineRx Ltd. Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 American Society of Hematology Annual Meeting
11/7/2012
More...
|
Basilea Pharmaceutica (BSLN.SW)'s Novel Oncology Drug Candidate BAL101553: Data Presented at International Conference Demonstrate Dual Mode of Action
11/6/2012
More...
|
American Heart Association Release: Drug Trio Improved Effectiveness of Cancer Treatment, Protected Heart
11/6/2012
More...
|
Isotechnika Pharma Inc. (ISA.TO)'s NICAM Portfolio Demonstrates Positive Anti-Viral Activity Against Several Important Viruses
11/6/2012
More...
|
Cleveland Biolabs Inc. (CBLI) Announces Publication of Studies on Effect of Entolimod™ (CBLB502) on Graft-Versus-Tumor Activity in Models of Allogeneic Bone Marrow Transplantation
11/6/2012
More...
|
Kamada Ltd. (KMDA.TA) Announces New Data on its Glassia Drug Supporting Its Diabetes Activities and Treatment of Additional Therapeutic Indications
11/6/2012
More...
|
Concert Pharmaceuticals, Inc. Presents Preclinical Results Demonstrating CTP-499, a Novel Treatment for Diabetic Kidney Disease, Ameliorated Renal Fibrosis and Inflammation In Vivo
11/2/2012
More...
|
Compugen Ltd. (CGEN) Announces Discovery of Two Novel Immune Checkpoint Targets for Cancer Immunotherapy
10/31/2012
More...
|
Idera Pharmaceuticals, Inc. (IDRA) Present New Data That Show Toll-like Receptor Antagonists Inhibit Inflammasome Activation and Suppress Induction of Interleukin 1 Beta in Autoimmune Disease Models
10/30/2012
More...
|
Arrowhead Research Corporation (ARWR) Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System
10/29/2012
More...
|
Provectus Pharmaceuticals Inc. Presents Nonclinical Data on Antitumor Immune Response to PV-10 Immuno-Chemoablation
10/29/2012
More...
|
Addex Therapeutics (ADXN.SW) Reports ADX71441 Reduces Alcohol Intake in a Preclinical Model of Alcohol Binge Drinking
10/29/2012
More...
|
Vascular Nanotransfer Technologies (“VNT”) Reports In Vivo Results for Its Paclitaxel Nano-Carrier Based Drug Coated Balloon (DCB) Technology
10/26/2012
More...
|
MiReven Announces Positive Preclinical Results for miR-7 in Head and Neck Cancer
10/25/2012
More...
|
Acceleron Pharma’s ACE-536 Corrects Anemia and Iron Overload in Preclinical Model of Beta-Thalassemia
10/25/2012
More...
|
Oxygen Biotherapeutics, Inc. (OXBO)’ Update on US Army-Funded Preclinical Studies Designed to Support the Safety Profile of Oxycyte PFC Emulsion Currently in Clinical Trials Overseas for Traumatic Brain Injury
10/25/2012
More...
|
Synergy Pharmaceuticals Highlights Mechanistic Features of Plecanatide, a Novel Investigational Drug for Chronic Idiopathic Constipation
10/23/2012
More...
|
QR Pharma Release: Posiphen Restores Brain Function, Cognition and Memory in Transgenic Alzheimer Mice
10/22/2012
More...
|